Bordetellae are important respiratory pathogens that cause pertussis (whooping cough) in humans and analogous diseases in domestic and wild animals. Immunity to Bordetella is poorly understood, in particular the early innate immune responses that contribute to inflammation, pathology, and the subsequent generation of adaptive immunity. Using B. bronchiseptica, which naturally infects mice, we show that Toll-like receptor-4 (TLR4) is required for cytokine responses to this pathogen's lipopolysaccharide (LPS) and that TLR4 deficiency results in impaired cytokine responses in vitro and in vivo. TLR4-deficient mice rapidly succumb following inoculation with as few as 1000 organisms, indicating that TLR4 is critical to innate host defense against bordetellosis.
cell surface molecules that are essential to innate and adaptive immune response. One of the best-studied PAMPs is lipopolysacharide (LPS), a powerful inflammatory stimulant that is the major component of the outer membrane of gram-negative bacteria. It is generally believed that most bacterial LPSs induce inflammatory responses via TLR4, but recent studies have indicated that TLR2 plays that role in the response to LPSs derived from certain nonenteric gram-negative bacteria [3] . Since the role that TLR4 plays in host defense against Bordetella has not yet been determined, we used the B. bronchiseptica mouse model of infection to investigate whether TLR4 is required for mediating protection during innate host defense of the respiratory tract.
Materials and methods. Bone marrow-derived macrophages (BMMs) were established as described elsewhere [4] . Cells were replated at ∼10 6 cells/well in 24-well plates (Corning Glass) with Dulbecco's modified Eagle medium containing either B. bronchiseptica LPS (a gift from A. Preston), Escherichia coli LPS (Sigma), Staphylococcus aureus peptidoglycan (Sigma), or heat-killed B. bronchiseptica. In vivo cytokine responses were determined in lungs homogenized in 1 mL of PBS 12 h after inoculation and stored at Ϫ80ЊC until assayed. The lung homogenate was later centrifuged at 400 g for 5 min, the supernatant was collected, and interleukin (IL)-6 concentrations were measured. IL-6 levels were measured by ELISA using appropriate standards, capture, and detection antibodies (R&D Systems). NO was estimated by use of Greiss reagent (Sigma). TLR4-deficient (TLR4   d   ) C3H/HeJ mice, TLR4-deleted (TLR4 del ) C57Bl/10ScNCR mice, and wild-type (WT) C57Bl/10ScSn mice were obtained from Jackson Laboratory. WT C3H/HeN mice were obtained from Charles River Laboratories. All mice were maintained in the animal-care facility at Pennsylvania State University, in accordance with institutional guidelines. Mice were inoculated with B. bronchiseptica as described elsewhere, and bacterial colonization was quantified as described elsewhere [5] . For histological assessment of the lung specimens, fixed hematoxylin-eosin-stained slides were examined by a pathologist (M.J.K.) blinded to the experimental treatment. Scoring was as follows: 0 indicates no lesions or inflammation; 1 indicates slight inflammation with few or scattered lesions and !10% of lung fields affected; 2 indicates mild lesions with 10%-20% of lung fields affected; 3 indicates moderate lesions and 21%-30% of lung fields affected; and 4 indicates extensive lesions, marked inflammation, and 130% of lung fields affected. Lung leukocytes were isolated as described elsewhere [6] . Leu- kocytes were separated on a Ficoll gradient (Sigma) and were enumerated on a hemacytometer (Hausser Scientific).
The mean ‫ע‬ SE was determined for each treatment group in the individual experiments. Statistical significance was calculated using an unpaired Student's t test with a significance level of for a single comparison. P ! .05 Results. WT BMMs responded to B. bronchiseptica LPS by releasing NO and IL-6 ( figure 1A and 1B) . Although WT BMMs responded to concentrations of LPS as low as 1 ng/mL (data not shown), the NO and IL-6 response of TLR4 d BMMs was not detectable at concentrations р1000 ng/mL (figure 1A and 1B), which suggests that TLR4 is required for cytokine responses to B. bronchiseptica LPS. WT BMMs produced significantly more IL-6 and NO, compared with TLR4 d BMMs, on exposure to heat-killed B. bronchiseptica ( figure 1A and 1B) , which suggests that the in vitro response to B. bronchiseptica is largely dependent on TLR4. Collectively, these results indicate that TLR4 plays an important role during in vitro responses to B. bronchiseptica.
Since it appears that TLR4 is a major mediator of cytokine responses to B. bronchiseptica in vitro, we sought to determine how the absence of TLR4 affected cytokine responses in vivo. We measured IL-6 in the lungs of WT and TLR4 d mice 12 h after inoculation with ∼ cfu of B. bronchiseptica. This 5 5 ϫ 10 inoculation regimen has been shown to consistently distribute bordetellae throughout the respiratory tract [5] . The lung homogenate of infected WT mice contained increased levels of IL-6 (figure 1C), tumor necrosis factor-a (data not shown), and IL-10 (data not shown), compared with that of infected TLR4 d mice. These results suggest that, in vivo, early-elicited cytokine responses to B. bronchiseptica are mainly mediated via interactions between LPS and TLR4.
To test whether TLR4 is important to host defense against B. bronchiseptica, groups of WT, TLR4 d , and TLR4 del mice were inoculated intranasally with ∼10 5 cfu of B. bronchiseptica. As observed elsewhere [5, 7] , WT mice endured this level of infection, showing no visible signs of distress and eventually eliminating the bacteria from the lower respiratory tract. However, TLR4 d and TLR4 del mice exhibited signs of severe bordetellosis, including hunched backs, ruffled fur, inflamed external nares, and labored breathing. The health of these animals rapidly deteriorated, and they all were killed ∼72 h after inoculation, to prevent suffering. Doses as low as 10 3 cfu of B. bronchiseptica delivered throughout the respiratory tract were lethal to TLR4 d and TLR4 del mice by day 7 after inoculation, whereas doses as high as 10 6 cfu were tolerated, with the mice showing few symptoms (data not shown), by several strains of WT mice (including C3H/HeN, C57Bl/10ScSn, C57BL/6, and BALB/c).
On day 3 after the mice were inoculated with ∼10 5 cfu, we excised the lungs and examined fixed hematoxylin-eosinstained sections, to evaluate the pathology induced by B. bronchiseptica infection. The lungs of WT mice exhibited perivascular and peribronchiolar lymphoid cuffing as well as mixed inflammatory cell infiltrates ( figure 2A) . The mean lung-lesion score for WT mice was 1.8 on the 4-point scale described above. The lungs of TLR4 d mice exhibited moderate to severe perivascular and peribronchiolar lymphoid cuffing as well as severe suppurative alveolar pneumonia with predominant neutrophilic infiltrates ( figure 2A ) and also contained significantly higher numbers of lesions as well as increased lesion severity and had a mean lung-lesion score of 3.7. The total leukocyte count for collagenase-digested lungs was significantly elevated in TLR4 d mice, compared with WT mice ( figure 2B ). Gross examination of the lungs of TLR4 del mice showed pathology similar to that seen in TLR4 d mice (data not shown). These results suggest that TLR4 is required to mediate lung pathology and to prevent B. bronchiseptica-induced pneumonia.
To determine the role that TLR4 plays in limiting bacterial levels during B. bronchiseptica infection, groups of WT (C3H/ HeN and C57Bl/10ScSn) mice, TLR4 d (C3H/HeJ) mice, and TLR4 del (C57Bl/10ScNCr) mice were inoculated with ∼10 5 cfu of B. bronchiseptica. The mice were killed ∼24 h after inoculation, and colonization levels in the nasal cavity, trachea, and lungs were determined. The nasal cavities of both WT mouse strains contained ∼10 5 cfu of B. bronchiseptica, and the tracheas contained ∼10 4 cfu ( figure 2C ). The nasal cavities and tracheas of TLR4 d mice and TLR4 del mice contained у10-fold-higher levels of B. bronchiseptica. The lungs of both WT mouse strains contained ∼10 5 -10 6 cfu of B. bronchiseptica, whereas the lungs of TLR4 d mice and TLR4 del mice contained 1100-fold-higher levels of this bacterium. Collectively, these results indicate that TLR4 is critical to protection against acute infection by B. bronchiseptica.
Discussion. The reported roles that TLR4 plays during respiratory infection by various gram-negative, gram-positive, and viral pathogens differ widely [8] [9] [10] [11] [12] . B. bronchiseptica naturally colonizes the respiratory tract of mice, and this infection model has been shown to facilitate the examination of specific host defense mechanisms in respiratory immunity [5, 7] . Therefore, we used this model to investigate TLR4-dependent innate defenses to bordetellae throughout the respiratory tract, in the context of natural interactions between host and pathogen.
The results of our in vitro studies revealed that murine TLR4 is essential for the proinflammatory cytokine response to B. bronchiseptica LPS and that it plays a major role in the detection of and response to heat-killed B. bronchiseptica. Similarly, TLR4 is a major mediator of in vivo cytokine production shortly after infection by B. bronchiseptica. Although several strains of WT mice show no signs of distress after acute challenges, both TLR4 d mice and TLR4 del mice rapidly develop fatal B. bronchiseptica-induced pneumonia. Histological examination of the lungs of TLR4 d mice 72 h after inoculation showed greatly increased mononuclear and neutrophilic infiltrates, compared with WT mice. In addition, our results show that TLR4 is critical in the control of B. bronchiseptica colonization levels in the nasal cavity, trachea, and lungs. To our knowledge, this is the only evidence of the increased susceptibility of TLR4 d mice to a natural mouse pathogen when they are inoculated via a regimen that closely mimics natural infection.
Recently, mutations in human TLR4 have been associated with diminished airway responses to LPS, as well as with increased susceptibility to infection by gram-negative bacteria [13, 14] . Other studies have shown lower levels of TLR4 expression in the lungs of newborn mice, compared with adult mice [15] , a finding that correlates with the newborns' increased susceptibility to bordetellosis. Whether TLR4 signaling defects play a role in increased susceptibility to pertussis disease remains to be determined; however, the results of the present study suggest that TLR4 plays a critical role in innate host defense against Bordetella infection.
